Health pharmacogenomics / NHS England Impact 2.0/10 2 min read

NHS to Test Pharmacogenomics in Medication Prescription

The NHS in England will launch a pilot programme in June 2023 to test pharmacogenomics in medication prescription. The programme aims to ensure patients receive appropriate drugs and minimize side effects. Over 90% of individuals have genetic variations affecting drug response. A study in The Lancet found pharmacogenetics-guided prescribing could reduce adverse drug reactions by 30%. The University of Manchester leads the pilot, with plans to expand nationally if successful.

Unverified optimistic

📊 Story at a Glance

M

Source

Maldives Republic

Original

Visit source ↗

Published

Jun 11, 2023

Reading

2 min

Views

0

📋 Story Brief

The NHS in England will launch a pilot programme in June 2023 to test pharmacogenomics in medication prescription. The programme aims to ensure patients receive appropriate drugs and minimize side effects. Over 90% of individuals have genetic variations affecting drug response. A study in The Lancet found pharmacogenetics-guided prescribing could reduce adverse drug reactions by 30%. The University of Manchester leads the pilot, with plans to expand nationally if successful.

💡 Why It Matters

This story involves 1 source and may affect public understanding of pharmacogenomics / nhs.

⚖️ How Sources Compare

🔍 How Each Source Covered This

Maldives Republic News Outlet Single source

Angle: Primary coverage

Focus: NHS to Test Pharmacogenomics in Medication Prescription

Unique detail: NHS to Test Pharmacogenomics in Medication Prescription

📅 Timeline

12:36

Initial report published

Maldives Republic

👁️ What To Watch

1

Official government or institutional statement

2

Further reporting from additional sources

3

Public and social media reaction

4

Related policy or operational changes